The underlying mechanism may be that SGPL1 gene mutation increases S1P production, activates plasma cells, and results in the continuous proliferation of plasma cells and increased secretion of monoclonal IgA-κ protein, which is deposited in various organs, leading to the occurrence of amyloidosis. Here, SGPL1 is linked to amyloidosis.